PET scans in radiotherapy planning of lung cancer

被引：61

作者：

De Ruysscher, Dirk ^{[1
]}

Kirsch, Carl-Martin ^{[2
]}

机构：

[1] Maastricht Univ, Med Ctr, Dept Radiat Oncol, MAASTRO Clin,GROW Res Inst, Maastricht, Netherlands

[2] Univ Saarland, Med Ctr, Dept Nucl Med, D-6650 Homburg, Germany

来源：

RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷 / 03期

关键词：

Radiotherapy; PET; Lung cancer; Delineation; Target volumes; UNSUSPECTED DISTANT METASTASES; POSITRON-EMISSION-TOMOGRAPHY; TARGET VOLUME DEFINITION; FDG-PET; PROGNOSTIC STRATIFICATION; DOSE-ESCALATION; PRIMARY TUMOR; LYMPH-NODES; CT; DELINEATION;

D O I：

10.1016/j.radonc.2010.07.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Especially for non-small cell lung cancer. FOG-PET has in the majority of the patients led to the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and, experimentally, redistribution of radiation doses within the tumor. In limited-disease small cell lung cancer, the role of FDG-PET is emerging. (C) 2010 European Society for Therapeutic Radiology and Oncology and European Association of Nuclear Medicine. Published by Elsevier Ireland Ltd. All rights reserved. 96 (2010) 335-338

引用

页码：335 / 338

页数：4

共 39 条

[1] Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC:: A prospective study [J].

Aerts, Hugo J. W. L. ;

Bosmans, Geert ;

van Baardwijk, Angela A. W. ;

Dekker, Andre L. A. J. ;

Oellers, Michel C. ;

Lambin, Philippe ;

De Ruysscher, Dirk .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05) :1402-1407

[2] Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan [J].

Aerts, Hugo J. W. L. ;

van Baardwijk, Angela A. W. ;

Petit, Steven F. ;

Offermann, Claudia ;

van Loon, Judith ;

Houben, Ruud ;

Dingemans, Anne-Marie C. ;

Wanders, Rinus ;

Boersma, Liesbeth ;

Borger, Jacques ;

Bootsma, Gerben ;

Geraedts, Wiel ;

Pitz, Cordula ;

Simons, Jean ;

Wouters, Bradly G. ;

Oellers, Michel ;

Lambin, Philippe ;

Bosmans, Geert ;

Dekker, Andre L. A. J. ;

De Ruysscher, Dirk .

RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) :386-392

[3] Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy [J].

Belderbos, Jose S. A. ;

Heemsbergen, Wilma D. ;

De Jaeger, Katrien ;

Baas, Paul ;

Lebesque, Joos V. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01) :126-134

[4] The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials [J].

Boellaard, Ronald ;

Oyen, Wim J. G. ;

Hoekstra, Corneline J. ;

Hoekstra, Otto S. ;

Visser, Eric P. ;

Willemsen, Antoon T. ;

Arends, Bertjan ;

Verzijlbergen, Fred J. ;

Zijlstra, Josee ;

Paans, Anne M. ;

Comans, Emile F. I. ;

Pruim, Jan .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (12) :2320-2333

[5] Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer [J].

Brink, I ;

Schumacher, T ;

Mix, M ;

Ruhland, S ;

Stoelben, E ;

Digel, W ;

Henke, M ;

Ghanem, N ;

Moser, E ;

Nitzsche, EU .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (12) :1614-1620

[6] The limitation of PET imaging for biological adaptive-IMRT assessed in animal models [J].

Christian, Nicolas ;

Lee, John A. ;

Bol, Anne ;

De Bast, Marc ;

Jordan, B. ;

Gregoire, Vincent .

RADIOTHERAPY AND ONCOLOGY, 2009, 91 (01) :101-106

[7] Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study [J].

De Ruysscher, D ;

Wanders, S ;

Van Haren, E ;

Hochstenbag, M ;

Geeraedts, W ;

Utama, I ;

Simons, J ;

Dohmen, J ;

Rhami, A ;

Buell, U ;

Thimister, P ;

Snoep, G ;

Boersma, L ;

Verschueren, T ;

Van Baardwijk, A ;

Minken, A ;

Bentzen, SM ;

Lambin, P .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (04) :988-994

[8] Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose Limiting normal tissues and radiation dose-escalation:: A planning study [J].

De Ruysscher, D ;

Wanders, S ;

Minken, A ;

Lumens, A ;

Schiffelers, J ;

Stultiens, C ;

Halders, S ;

Boersma, L ;

van Baardwijk, A ;

Verschueren, T ;

Hochstenbag, M ;

Snoep, G ;

Wouters, B ;

Nijsten, S ;

Bentzen, SM ;

van Kroonenburgh, M ;

Öllers, M ;

Lambin, P .

RADIOTHERAPY AND ONCOLOGY, 2005, 77 (01) :5-10

[9] Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: A model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography [J].

Dooms, Christophe ;

Verbeken, Eric ;

Stroobants, Sigrid ;

Nackaerts, Kris ;

De Leyn, Paul ;

Vansteenkiste, Johan .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) :1128-1134

[10] IMAGING CELLULAR PROLIFERATION DURING CHEMO-RADIOTHERAPY: A PILOT STUDY OF SERIAL 18F-FLT POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IMAGING FOR NON-SMALL-CELL LUNG CANCER [J].

Everitt, Sarah ;

Hicks, Rodney J. ;

Ball, David ;

Kron, Tomas ;

Schneider-Kolsky, Michal ;

Walter, Tania ;

Binns, David ;

Mac Manus, Michael .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (04) :1098-1104

← 1 2 3 4 →